Literature DB >> 35135780

Syndromes of Pseudo-Hyperaldosteronism.

Katherine Rizzolo1, Natalie M Beck2, Sophia L Ambruso2,3.   

Abstract

Entities:  

Keywords:  aldosterone; hypertension; hypokalemia

Mesh：

Substances：

Year:  2022        PMID： 35135780      PMCID： PMC8993470          DOI： 10.2215/CJN.14201021

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  10 in total

Review 1.  Use of prednisone with abiraterone acetate in metastatic castration-resistant prostate cancer.

Authors:  Richard J Auchus; Margaret K Yu; Suzanne Nguyen; Suneel D Mundle
Journal:  Oncologist       Date:  2014-10-31

2.  Tissue-specific Cushing's syndrome, 11beta-hydroxysteroid dehydrogenases and the redefinition of corticosteroid hormone action.

Authors:  Paul M Stewart
Journal:  Eur J Endocrinol       Date:  2003-09       Impact factor: 6.664

3.  Molecular mechanisms of posaconazole- and itraconazole-induced pseudohyperaldosteronism and assessment of other systemically used azole antifungals.

Authors:  Katharina R Beck; Lucija Telisman; Chris J van Koppen; George R Thompson; Alex Odermatt
Journal:  J Steroid Biochem Mol Biol       Date:  2020-01-23       Impact factor: 4.292

4.  Efficacy of Eplerenone in the Management of Mineralocorticoid Excess in Men With Metastatic Castration-resistant Prostate Cancer Treated With Abiraterone Without Prednisone.

Authors:  David Gill; David Gaston; Erin Bailey; Andrew Hahn; Sumati Gupta; Julia Batten; Anitha Alex; Kenneth Boucher; David Stenehjem; Neeraj Agarwal
Journal:  Clin Genitourin Cancer       Date:  2017-01-05       Impact factor: 2.872

5.  Amiloride Is Effective in the Management of Abiraterone-Induced Mineralocorticoid Excess Syndrome without Interfering with Its Antineoplastic Activity.

Authors:  Francesca Bedussi; Diego Galli; Martina Fragni; Francesca Valcamonico; Elisa Rossini; Alberto Dalla Volta; Sara Vezzoli; Elisa Roca; Vittorio Ferrari; Barbara Lazzari; Maurizio Memo; Sandra Sigala; Alfredo Berruti
Journal:  Pharmacology       Date:  2017-08-11       Impact factor: 2.547

6.  A physiologic-based approach to the evaluation of a patient with hypokalemia.

Authors:  Biff F Palmer
Journal:  Am J Kidney Dis       Date:  2010-09-15       Impact factor: 8.860

Review 7.  Strategies for managing ACTH dependent mineralocorticoid excess induced by abiraterone.

Authors:  Anna Pia; Francesca Vignani; Gerhardt Attard; Marcello Tucci; Paolo Bironzo; Giorgio Scagliotti; Wiebke Arlt; Massimo Terzolo; Alfredo Berruti
Journal:  Cancer Treat Rev       Date:  2013-04-10       Impact factor: 12.111

Review 8.  Investigating mineralocorticoid hypertension.

Authors:  Jürg Nussberger
Journal:  J Hypertens Suppl       Date:  2003-05

9.  The diagnosis of primary aldosteronism and separation of two major subtypes.

Authors:  M H Weinberger; N S Fineberg
Journal:  Arch Intern Med       Date:  1993-09-27

Review 10.  Licorice: From Pseudohyperaldosteronism to Therapeutic Uses.

Authors:  Chiara Sabbadin; Luciana Bordin; Gabriella Donà; Jacopo Manso; Giampiero Avruscio; Decio Armanini
Journal:  Front Endocrinol (Lausanne)       Date:  2019-07-18       Impact factor: 5.555
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.